Fig. 1From: Blood eosinophils as a biomarker of future COPD exacerbation risk: pooled data from 11 clinical trialsBaseline blood eosinophil levels in the total population. Baseline blood eosinophil count from 22,125 patients with accompanying exacerbation dataBack to article page